Trial
NCT07014735
Effect of Hyperglycaemia and Moxifloxacin on QTc Interval in T2DM
UnknownTERMINATEDEFFICACY/FUTILITYConfidence: HIGH
Sponsor
Richmond Pharmacology Limited
Collaborators
Richmond Research Institute
Condition
Diabetes Type 2
Intervention
glucose
Why stopped
The study is being terminated early on the grounds of futility, as continuation of the study is no longer considered scientifically or operationally justified.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-07-01